Effect of PGE1 on TNF-α status and hepatic D-galactosamine-induced apoptosis in rats

被引:35
作者
Muntane, J
Montero, JL
Marchal, T
Perez-Seoane, C
Lozano, JM
Fraga, E
Pintado, CO
De la Mata, M
Mino, G
机构
[1] Hosp Univ Reina Sofia, Serv Aparato Digest, Unidad Invest, Cordoba 14004, Spain
[2] Hosp Univ Reina Sofia, Serv Anat Patol, Cordoba, Spain
关键词
aminotransferase; apoptosis; D-galactosamine; fulminant hepatic failure; PGE(1); rat; TNF-alpha;
D O I
10.1111/j.1440-1746.1998.tb00638.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Prostaglandin E-1 has hepatoprotective properties in several clinical and experimental models of liver dysfunction. Hepatotoxicity induced by D-galactosamine (D-GalN) is a suitable animal model of human acute hepatic failure. The aim of the study was to investigate if prostaglandin E-1 (PGE(1)) protection against hepatic D-GalN-induced apoptosis was related to tumour necrosis factor-alpha (TNF-alpha) content in serum. This cytokine is associated with in vitro apoptosis and general inflammatory disorders. In this study, PGE(1) was administered 30 min before D-GalN to rats. In other experiments, several doses of TNF-alpha were administered 15min after PGE(1) to D-GalN-treated rats. Several parameters related to apoptosis and necrosis were measured by flow cytometry, gel electrophoresis, biochemical analysis, and optical and electron microscopy. Tumour necrosis factor-or was quantified by competitive enzyme-linked immunosorbent assay (ELISA). PGE(1) by itself did not modify the cell cycle of hepatocytes and liver toxicity, but increased TNF-alpha in serum in comparison with the control group. D-Galactosamine increased the percentage of hepatocytes in apoptosis and in the S phase of the cell cycle, and decreased those in G(o)/G(1),. Such an increase of hepatocytes in apoptosis was correlated with a higher number of apoptotic bodies and DNA fragmentation in liver than control samples. Also, D-GalN increased alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and TNF-alpha in serum compared with the control group. Pre-administration of PGE(1) to D-GalN-treated rats reduced all the parameters of apoptosis and necrosis in liver, and increased additionally TNF-alpha content in serum. In those experiments where low doses of TNF-alpha were administered to PGE(1) and D-GalN-treated rats an inverse relationship appeared between TNF-alpha and ALT content in serum. In conclusion, the protective effects of PGE(1) on D-GalN-induced apoptosis may be linked to its capacity to modulate cell division and/or its immunomodulatory activity. In this sense, our experimental results suggest that TNF-alpha could be involved in protection or exacerbation of liver damage in relation to the pathophysiological status of the liver.
引用
收藏
页码:197 / 207
页数:11
相关论文
共 47 条
[1]   16,16-DIMETHYL PROSTAGLANDIN-E2 PREVENTS THE DEVELOPMENT OF FULMINANT-HEPATITIS AND BLOCKS THE INDUCTION OF MONOCYTE MACROPHAGE PROCOAGULANT ACTIVITY AFTER MURINE HEPATITIS-VIRUS STRAIN-3 INFECTION [J].
ABECASSIS, M ;
FALK, JA ;
MAKOWKA, L ;
DINDZANS, VJ ;
FALK, RE ;
LEVY, GA .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (03) :881-889
[2]   MECHANISMS OF CLASS-I RESTRICTED IMMUNOPATHOLOGY - A TRANSGENIC MOUSE MODEL OF FULMINANT-HEPATITIS [J].
ANDO, K ;
MORIYAMA, T ;
GUIDOTTI, LG ;
WIRTH, S ;
SCHREIBER, RD ;
SCHLICHT, HJ ;
HUANG, SN ;
CHISARI, FV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1541-1554
[3]   HEPATIC AND GASTRIC CYTOPROTECTIVE EFFECTS OF LONG-TERM PROSTAGLANDIN-E1 ADMINISTRATION IN CIRRHOTIC RATS [J].
BECK, PL ;
MCKNIGHT, GW ;
KELLY, JK ;
WALLACE, JL ;
LEE, SS .
GASTROENTEROLOGY, 1993, 105 (05) :1483-1489
[4]  
BERGASA NV, 1992, LIVER, V12, P168
[5]  
DARZYNKIEWICZ Z, 1994, METHOD CELL BIOL, V41, P15
[6]  
DECKER K, 1972, P183
[7]   EFFECTS OF PROSTAGLANDIN-E2 ON BRAIN EDEMA AND LIVER HISTOPATHOLOGY IN A GALACTOSAMINE-INDUCED FULMINANT HEPATIC-FAILURE RAT MODEL [J].
DIXIT, V ;
CHANG, TMS .
BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS, 1987, 15 (03) :559-573
[8]   MECHANISMS AND FUNCTIONS OF CELL-DEATH [J].
ELLIS, RE ;
YUAN, JY ;
HORVITZ, HR .
ANNUAL REVIEW OF CELL BIOLOGY, 1991, 7 :663-698
[9]  
FAA G, 1992, J SUBMICR CYTOL PATH, V24, P417
[10]   PROSTAGLANDIN-E2 INHIBITS THE RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA, RATHER THAN INTERLEUKIN-1-BETA, FROM HUMAN MACROPHAGES [J].
FIEREN, MWJA ;
VANDENBEMD, GJCM ;
BENEFRAIM, S ;
BONTA, IL .
IMMUNOLOGY LETTERS, 1992, 31 (01) :85-90